Literature DB >> 16314608

Psychosocial factors predict CD4 and viral load change in men and women with human immunodeficiency virus in the era of highly active antiretroviral treatment.

Gail Ironson1, Conall O'Cleirigh, Mary Ann Fletcher, Jean Philippe Laurenceau, Elizabeth Balbin, Nancy Klimas, Neil Schneiderman, George Solomon.   

Abstract

OBJECTIVE: Most previous longitudinal studies demonstrating relationships between psychosocial variables and human immunodeficiency virus (HIV) disease progression utilized samples of gay men accrued before the era of highly active antiretroviral treatment (HAART), without including viral load (VL) as an indicator of disease progression or assessing the impact of medication adherence. This study sought to determine whether psychosocial variables would predict both CD4 and VL changes in a diverse sample assessed entirely during the era of HAART and accounting for adherence effects.
METHODS: This longitudinal study assessed a multiethnic HIV+ sample (n = 177) of men and women in the midrange of illness (CD4 number between 150 and 500; no previous acquired immunodeficiency syndrome [AIDS]-defining symptom) every 6 months for 2 years. Hierarchical linear modeling was used to model change in CD4 and VL controlling for sociodemographics (age, gender, ethnicity, education) and medical variables (baseline CD4/VL, antiretroviral medications at each time point, adherence).
RESULTS: Baseline depression, hopelessness, and education predicted the slope of CD4 and VL. Avoidant coping and life event stress predicted VL change. Cumulative variables produced stronger relationships (depression, avoidant coping, and hopelessness with CD4/VL slope and life events stress with VL slope). High cumulative depression and avoidant coping were associated with approximately twice the rate of decline in CD4 as low scorers and greater relative increases in VL. Social support was not significantly related to CD4 or VL slope.
CONCLUSIONS: Psychosocial factors contribute significantly to the variance in HIV disease progression (assessed through CD4 number and VL) in a diverse sample, accounting for adherence and do so in the era of HAART.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16314608      PMCID: PMC2614887          DOI: 10.1097/01.psy.0000188569.58998.c8

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  50 in total

1.  A short social support measure for patients recovering from myocardial infarction: the ENRICHD Social Support Inventory.

Authors:  Pamela H Mitchell; Lynda Powell; James Blumenthal; Jennifer Norten; Gail Ironson; Carol Rogers Pitula; Erika Sivarajan Froelicher; Susan Czajkowski; Marston Youngblood; Marc Huber; Lisa F Berkman
Journal:  J Cardiopulm Rehabil       Date:  2003 Nov-Dec       Impact factor: 2.081

2.  Fluoxetine treatment for depression in patients with HIV and AIDS: a randomized, placebo-controlled trial.

Authors:  J G Rabkin; G J Wagner; R Rabkin
Journal:  Am J Psychiatry       Date:  1999-01       Impact factor: 18.112

3.  Social relationships and immune processes in HIV seropositive gay and bisexual men.

Authors:  G E Miller; M E Kemeny; S E Taylor; S W Cole; B R Visscher
Journal:  Ann Behav Med       Date:  1997

4.  Progression to AIDS: the effects of stress, depressive symptoms, and social support.

Authors:  J Leserman; E D Jackson; J M Petitto; R N Golden; S G Silva; D O Perkins; J Cai; J D Folds; D L Evans
Journal:  Psychosom Med       Date:  1999 May-Jun       Impact factor: 4.312

5.  Impaired response to HAART in HIV-infected individuals with high autonomic nervous system activity.

Authors:  S W Cole; B D Naliboff; M E Kemeny; M P Griswold; J L Fahey; J A Zack
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-23       Impact factor: 11.205

6.  Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease.

Authors:  S L Catz; J A Kelly; L M Bogart; E G Benotsch; T L McAuliffe
Journal:  Health Psychol       Date:  2000-03       Impact factor: 4.267

7.  [Adherence to antiretroviral therapy measured by pill count and drug serum concentrations. Variables associated with a bad adherence].

Authors:  Melcior Riera; Laura de La Fuente Ld; Bartomeu Castanyer; Francesc Puigventós; Concepción Villalonga; M Angels Ribas; Antonio Pareja; Maria Leyes; Ana Salas
Journal:  Med Clin (Barc)       Date:  2002-09-14       Impact factor: 1.725

8.  Psychosocial self-prognosis in relation to mortality and morbidity in hemophiliacs with HIV infection.

Authors:  V Blomkvist; T Theorell; H Jonsson; S Schulman; E Berntorp; L Stiegendal
Journal:  Psychother Psychosom       Date:  1994       Impact factor: 17.659

9.  Norepinephrine accelerates HIV replication via protein kinase A-dependent effects on cytokine production.

Authors:  S W Cole; Y D Korin; J L Fahey; J A Zack
Journal:  J Immunol       Date:  1998-07-15       Impact factor: 5.422

10.  Depressive symptoms and CD4 lymphocyte decline among HIV-infected men.

Authors:  J H Burack; D C Barrett; R D Stall; M A Chesney; M L Ekstrand; T J Coates
Journal:  JAMA       Date:  1993-12-01       Impact factor: 56.272

View more
  138 in total

1.  OPRM1 and diagnosis-related posttraumatic stress disorder in binge-drinking patients living with HIV.

Authors:  Nicole R Nugent; Michelle A Lally; Larry Brown; Valerie S Knopik; John E McGeary
Journal:  AIDS Behav       Date:  2012-11

2.  HIV-Related Stigma, Shame, and Avoidant Coping: Risk Factors for Internalizing Symptoms Among Youth Living with HIV?

Authors:  David S Bennett; Jill Hersh; Joanna Herres; Jill Foster
Journal:  Child Psychiatry Hum Dev       Date:  2016-08

3.  Effects of syndemics on HIV viral load and medication adherence in the multicentre AIDS cohort study.

Authors:  M Reuel Friedman; Ron Stall; Anthony J Silvestre; Chongyi Wei; Steve Shoptaw; Amy Herrick; Pamela J Surkan; Linda Teplin; Michael W Plankey
Journal:  AIDS       Date:  2015-06-01       Impact factor: 4.177

4.  Associations among depression, suicidal behavior, and quality of life in patients with human immunodeficiency virus.

Authors:  Gianluca Serafini; Franco Montebovi; Dorian A Lamis; Denise Erbuto; Paolo Girardi; Mario Amore; Maurizio Pompili
Journal:  World J Virol       Date:  2015-08-12

Review 5.  Future directions for interventions targeting PTSD in HIV-infected adults.

Authors:  Allison J Applebaum; C Andres Bedoya; Ellen S Hendriksen; Jesse L Wilkinson; Steven A Safren; Conall O'Cleirigh
Journal:  J Assoc Nurses AIDS Care       Date:  2014-11-10       Impact factor: 1.354

6.  Improving Depression Among HIV-Infected Adults: Transporting the Effect of a Depression Treatment Intervention to Routine Care.

Authors:  Angela M Bengtson; Brian W Pence; Bradley N Gaynes; E Byrd Quinlivan; Amy D Heine; Julie K OʼDonnell; Heidi M Crane; W Christopher Mathews; Richard D Moore; Daniel Westreich; Conall OʼCleirigh; Katerina Christopoulos; Matthew J Mimiaga; Michael J Mugavero
Journal:  J Acquir Immune Defic Syndr       Date:  2016-12-01       Impact factor: 3.731

7.  How have long-term survivors coped with living with HIV?

Authors:  Jacquelyn Slomka; Jung-won Lim; Barbara Gripshover; Barbara Daly
Journal:  J Assoc Nurses AIDS Care       Date:  2012-12-17       Impact factor: 1.354

8.  Does the occurrence of adverse life events in patients with breast cancer lead to a change in illness behaviour?

Authors:  Siegfried Geyer; Dorothee Noeres; Mariya Mollova; Heike Sassmann; Alexandra Prochnow; Mechthild Neises
Journal:  Support Care Cancer       Date:  2008-07-29       Impact factor: 3.603

9.  Depressive Symptoms at HIV Testing and Two-Year All-Cause Mortality Among Men Who Inject Drugs in Vietnam.

Authors:  Sara N Levintow; Brian W Pence; Tran Viet Ha; Nguyen Le Minh; Teerada Sripaipan; Carl A Latkin; Pham The Vu; Vu Minh Quan; Constantine Frangakis; Vivian F Go
Journal:  AIDS Behav       Date:  2019-03

10.  Examination of using alcohol to cope, depressive symptoms, and perceived social support in persons with HIV and Hepatitis C.

Authors:  Ethan Moitra; Bradley J Anderson; Debra S Herman; Jumi Hayaki; Megan M Pinkston; H Nina Kim; Michael D Stein
Journal:  AIDS Care       Date:  2020-02-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.